SCHEMBL7127296

SCHEMBL7127296

[O]c1ccccc1-n1ccc2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKD3 O94806 1/20 0.50
PRKCG P05129 1/20 0.50
PRKCB P05771 1/20 0.50
PRKCA P17252 1/20 0.50
PRKACA P17612 1/20 0.50
PRKACG P22612 1/20 0.50
PRKACB P22694 1/20 0.50
PRKCH P24723 1/20 0.50
PRKCI P41743 1/20 0.50
PRKCE Q02156 1/20 0.50
PRKCQ Q04759 1/20 0.50
PRKCZ Q05513 1/20 0.50
PRKCD Q05655 1/20 0.50
PRKD1 Q15139 1/20 0.50
BIRC5 O15392 1/20 0.47
CA12 O43570 2/20 0.42
CA9 Q16790 2/20 0.42
BRD4 O60885 1/20 0.42
BRPF1 P55201 1/20 0.42
KAT2B Q92831 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6989379 0.80 BIRC5 (0.47) PRKD3PRKCGPRKCBPRKCAPRKACA
SCHEMBL31116761 0.80 BIRC5 (0.47) PRKD3PRKCGPRKCBPRKCAPRKACA
SCHEMBL17072846 0.76 PRKD3 (0.50) PRKD3PRKCGPRKCBPRKCAPRKACA
SCHEMBL5661417 0.76 BIRC5 (0.47) PRKD3PRKCGPRKCBPRKCAPRKACA
SCHEMBL5604900 0.76 BIRC5 (0.47) PRKD3PRKCGPRKCBPRKCAPRKACA
SCHEMBL23075523 0.76 BIRC5 (0.47) PRKD3PRKCGPRKCBPRKCAPRKACA
SCHEMBL2187570 0.76 BIRC5 (0.47) PRKD3PRKCGPRKCBPRKCAPRKACA
SCHEMBL2410450 0.76 TRAP1 (0.50) PRKD3PRKCGPRKCBPRKCAPRKACA
SCHEMBL983397 0.76 CDC7 (0.49) PRKD3PRKCGPRKCBPRKCAPRKACA
SCHEMBL31116722 0.76 BIRC5 (0.56) PRKD3PRKCGPRKCBPRKCAPRKACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004020408-A1 INDOLES HAVING ANTI-DIABETIC ACTIVITY MERCK & CO., INC. (US) 2004-03-11 WO disclosed